JNJ

230.18

+2.59%↑

ABT

90.97

-1.27%↓

MDT

83.35

+0.34%↑

A

114.25

-5.85%↓

VEEV

154.36

-6.48%↓

JNJ

230.18

+2.59%↑

ABT

90.97

-1.27%↓

MDT

83.35

+0.34%↑

A

114.25

-5.85%↓

VEEV

154.36

-6.48%↓

JNJ

230.18

+2.59%↑

ABT

90.97

-1.27%↓

MDT

83.35

+0.34%↑

A

114.25

-5.85%↓

VEEV

154.36

-6.48%↓

JNJ

230.18

+2.59%↑

ABT

90.97

-1.27%↓

MDT

83.35

+0.34%↑

A

114.25

-5.85%↓

VEEV

154.36

-6.48%↓

JNJ

230.18

+2.59%↑

ABT

90.97

-1.27%↓

MDT

83.35

+0.34%↑

A

114.25

-5.85%↓

VEEV

154.36

-6.48%↓

Search

Omnicell Inc

Abierto

SectorSanidad

36.91 2.67

Resumen

Variación precio

24h

Actual

Mínimo

35.74

Máximo

36.74

Métricas clave

By Trading Economics

Ingresos

-7.5M

-2M

Ventas

3.4M

314M

P/B

Media del Sector

945

60.328

Margen de beneficios

-0.645

Empleados

3,580

EBITDA

-9.8M

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+57.14% upside

Dividendos

By Dow Jones

Próximas Ganancias

28 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-518M

1.7B

Apertura anterior

34.24

Cierre anterior

36.91

Noticias sobre sentimiento de mercado

By Acuity

52%

48%

310 / 348 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 abr 2026, 23:33 UTC

Ganancias

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 abr 2026, 22:40 UTC

Ganancias

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 abr 2026, 22:10 UTC

Adquisiciones, fusiones, absorciones

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 abr 2026, 21:11 UTC

Ganancias

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 abr 2026, 21:01 UTC

Ganancias

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 abr 2026, 23:46 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

22 abr 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 abr 2026, 23:34 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 abr 2026, 23:16 UTC

Ganancias

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 abr 2026, 23:15 UTC

Ganancias

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 abr 2026, 22:54 UTC

Ganancias

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 abr 2026, 22:54 UTC

Ganancias

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 abr 2026, 22:52 UTC

Ganancias

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 abr 2026, 22:51 UTC

Ganancias

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 abr 2026, 22:31 UTC

Ganancias

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 abr 2026, 22:31 UTC

Ganancias

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 abr 2026, 22:30 UTC

Ganancias

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 abr 2026, 22:30 UTC

Ganancias

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 abr 2026, 22:29 UTC

Ganancias

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 abr 2026, 22:28 UTC

Ganancias

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 abr 2026, 22:28 UTC

Ganancias

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 abr 2026, 22:27 UTC

Ganancias

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 abr 2026, 22:06 UTC

Charlas de Mercado
Ganancias

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 abr 2026, 21:55 UTC

Adquisiciones, fusiones, absorciones

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 abr 2026, 21:47 UTC

Ganancias

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 abr 2026, 21:37 UTC

Ganancias

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 abr 2026, 21:34 UTC

Ganancias

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 abr 2026, 21:29 UTC

Ganancias

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 abr 2026, 21:20 UTC

Charlas de Mercado
Ganancias

Tesla Expands Manufacturing to Chips -- Market Talk

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

57.14% repunte

Estimación a 12 Meses

Media 57.75 USD  57.14%

Máximo 70 USD

Mínimo 49 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

5

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

310 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat